241 related articles for article (PubMed ID: 23767932)
21. Inducible packaging cells for large-scale production of lentiviral vectors in serum-free suspension culture.
Broussau S; Jabbour N; Lachapelle G; Durocher Y; Tom R; Transfiguracion J; Gilbert R; Massie B
Mol Ther; 2008 Mar; 16(3):500-7. PubMed ID: 18180776
[TBL] [Abstract][Full Text] [Related]
22. Large-scale manufacture and characterization of a lentiviral vector produced for clinical ex vivo gene therapy application.
Merten OW; Charrier S; Laroudie N; Fauchille S; Dugué C; Jenny C; Audit M; Zanta-Boussif MA; Chautard H; Radrizzani M; Vallanti G; Naldini L; Noguiez-Hellin P; Galy A
Hum Gene Ther; 2011 Mar; 22(3):343-56. PubMed ID: 21043787
[TBL] [Abstract][Full Text] [Related]
23. Development of second- and third-generation bovine immunodeficiency virus-based gene transfer systems.
Matukonis M; Li M; Molina RP; Paszkiet B; Kaleko M; Luo T
Hum Gene Ther; 2002 Jul; 13(11):1293-303. PubMed ID: 12162812
[TBL] [Abstract][Full Text] [Related]
24. Production of lentiviral vectors by transient expression of minimal packaging genes from recombinant adenoviruses.
Kuate S; Stefanou D; Hoffmann D; Wildner O; Uberla K
J Gene Med; 2004 Nov; 6(11):1197-205. PubMed ID: 15459964
[TBL] [Abstract][Full Text] [Related]
25. Construction of stable packaging cell lines for clinical lentiviral vector production.
Sanber KS; Knight SB; Stephen SL; Bailey R; Escors D; Minshull J; Santilli G; Thrasher AJ; Collins MK; Takeuchi Y
Sci Rep; 2015 Mar; 5():9021. PubMed ID: 25762005
[TBL] [Abstract][Full Text] [Related]
26. Production of trans-lentiviral vector with predictable safety.
Kappes JC; Wu X; Wakefield JK
Methods Mol Med; 2003; 76():449-65. PubMed ID: 12526179
[No Abstract] [Full Text] [Related]
27. Vectofusin-1 Improves Transduction of Primary Human Cells with Diverse Retroviral and Lentiviral Pseudotypes, Enabling Robust, Automated Closed-System Manufacturing.
Radek C; Bernadin O; Drechsel K; Cordes N; Pfeifer R; Sträßer P; Mormin M; Gutierrez-Guerrero A; Cosset FL; Kaiser AD; Schaser T; Galy A; Verhoeyen E; Johnston ICD
Hum Gene Ther; 2019 Dec; 30(12):1477-1493. PubMed ID: 31578886
[TBL] [Abstract][Full Text] [Related]
28. Efficient human hematopoietic cell transduction using RD114- and GALV-pseudotyped retroviral vectors produced in suspension and serum-free media.
Ghani K; Wang X; de Campos-Lima PO; Olszewska M; Kamen A; Rivière I; Caruso M
Hum Gene Ther; 2009 Sep; 20(9):966-74. PubMed ID: 19453219
[TBL] [Abstract][Full Text] [Related]
29. Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins.
Zhang XY; La Russa VF; Reiser J
J Virol; 2004 Feb; 78(3):1219-29. PubMed ID: 14722277
[TBL] [Abstract][Full Text] [Related]
30. A stable murine-based RD114 retroviral packaging line efficiently transduces human hematopoietic cells.
Ward M; Sattler R; Grossman IR; Bell AJ; Skerrett D; Baxi L; Bank A
Mol Ther; 2003 Nov; 8(5):804-12. PubMed ID: 14599814
[TBL] [Abstract][Full Text] [Related]
31. A multigene lentiviral vector system based on differential splicing.
Zhu Y; Planelles V
Methods Mol Med; 2003; 76():433-48. PubMed ID: 12526178
[No Abstract] [Full Text] [Related]
32. Specific transduction of HIV-1 envelope expressing cells by retroviral vectors pseudotyped with hybrid CD4/CXCR4 receptors.
Bittner A; Mitnacht-Kraus R; Schnierle BS
J Virol Methods; 2002 Jun; 104(1):83-92. PubMed ID: 12020795
[TBL] [Abstract][Full Text] [Related]
33. Advanced modular self-inactivating lentiviral expression vectors for multigene interventions in mammalian cells and in vivo transduction.
Mitta B; Rimann M; Ehrengruber MU; Ehrbar M; Djonov V; Kelm J; Fussenegger M
Nucleic Acids Res; 2002 Nov; 30(21):e113. PubMed ID: 12409472
[TBL] [Abstract][Full Text] [Related]
34. Introducing a cleavable signal peptide enhances the packaging efficiency of lentiviral vectors pseudotyped with Japanese encephalitis virus envelope proteins.
Liu H; Wu R; Yuan L; Tian G; Huang X; Wen Y; Ma X; Huang Y; Yan Q; Zhao Q; Cao S; Wen X
Virus Res; 2017 Feb; 229():9-16. PubMed ID: 27993624
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
Mautino MR; Keiser N; Morgan RA
J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
[TBL] [Abstract][Full Text] [Related]
36. Human immunodeficiency virus type 2 lentiviral vectors: packaging signal and splice donor in expression and encapsidation.
D'Costa J; Brown HM; Kundra P; Davis-Warren A; Arya SK
J Gen Virol; 2001 Feb; 82(Pt 2):425-434. PubMed ID: 11161282
[TBL] [Abstract][Full Text] [Related]
37. High-Titer Production of HIV-Based Lentiviral Vectors in Roller Bottles for Gene and Cell Therapy.
Olgun HB; Tasyurek HM; Sanlioglu AD; Sanlioglu S
Methods Mol Biol; 2019; 1879():323-345. PubMed ID: 29797007
[TBL] [Abstract][Full Text] [Related]
38. Genome editing for scalable production of alloantigen-free lentiviral vectors for
Milani M; Annoni A; Bartolaccini S; Biffi M; Russo F; Di Tomaso T; Raimondi A; Lengler J; Holmes MC; Scheiflinger F; Lombardo A; Cantore A; Naldini L
EMBO Mol Med; 2017 Nov; 9(11):1558-1573. PubMed ID: 28835507
[TBL] [Abstract][Full Text] [Related]
39. Genomic integration occurs in the packaging cell via unexported lentiviral precursors.
Mosabbir AA; Truong K
Biotechnol Lett; 2016 Oct; 38(10):1715-21. PubMed ID: 27341835
[TBL] [Abstract][Full Text] [Related]
40. Anti-HIV-1 gene expressing lentiviral vectors as an adjunctive therapy for HIV-1 infection.
Morris KV; Rossi JJ
Curr HIV Res; 2004 Apr; 2(2):185-91. PubMed ID: 15078182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
